CT53518

CT53518 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT53518, covering 2009-03-24 to 2009-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) [Phase 1]

See pricing